A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine.
Drug Metabol Drug Interact
; 20(4): 273-81, 2004.
Article
in En
| MEDLINE
| ID: mdl-15663296
ABSTRACT
The effect of ranitidine pretreatment on the pharmacokinetics of omeprazole was investigated in 14 male human volunteers. Omeprazole (40 mg, gastroresistant pellets) was administered to the volunteers in a two-treatment study design, either alone or after 5 days pretreatment with b.i.d. doses of 150 mg ranitidine. Plasma concentrations of omeprazole were determined over a 24-hour period following drug administration, by a validated RP-HPLC method. Pharmacokinetic parameters were calculated with compartmental and non-compartmental analysis, using the computer program Kinetica (Inna Phase). In the two periods of treatments, the mean peak plasma concentrations Cmax were 730.8 ng/ml for omeprazole alone and 802.1 ng/ml for omeprazole co-administered with ranitidine (not significant). The time taken to reach the peak, Tmax, was 1.29 h and 1.42 h, respectively (not significant). The areas under the curve (AUC0-10) were 1,453.3 ng.h/ml and 1,736.8 ng.h/ml for the two periods of treatment; thus a greater AUC was obtained after pretreatment with multiple doses of ranitidine. Our data show that the pharmacokinetics of omeprazole might be inhibited by pretreatment with ranitidine; however, the clinical relevance of this interaction still has to be confirmed.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ranitidine
/
Omeprazole
/
Histamine H2 Antagonists
/
Anti-Ulcer Agents
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Drug Metabol Drug Interact
Year:
2004
Document type:
Article